{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["IPSS score", "extant urine volume", "prostate volume", "quality of life"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "28532232", "DateCompleted": {"Year": "2018", "Month": "01", "Day": "05"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "13"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.1080/13880209.2017.1328445"], "Journal": {"ISSN": "1744-5116", "JournalIssue": {"Volume": "55", "Issue": "1", "PubDate": {"Year": "2017", "Month": "Dec"}}, "Title": "Pharmaceutical biology", "ISOAbbreviation": "Pharm Biol"}, "ArticleTitle": "A two-week, double-blind, placebo-controlled trial of Viola odorata, Echium amoenum and Physalis alkekengi mixture in symptomatic benign prostate hyperplasia (BPH) men.", "Pagination": {"StartPage": "1800", "EndPage": "1805", "MedlinePgn": "1800-1805"}, "Abstract": {"AbstractText": ["As an alternative approach, administration of phytotherapeutic agents in management of benign prostate hyperplasia (BPH), is rapidly growing each day. Different authors have indicated effectiveness of Viola odorata L. (Violaceae), Echium amoenum Fisch. & C.A.Mey. (Boraginaceae) and Physalis alkekengi L. (Solanaceae) in treatment of BPH. However, none have reported the beneficial outcomes of the mixture yet.", "This study evaluates the therapeutical effects of V. odorata, E. amoenum and P. alkekengi mixture on symptomatic BPH patients.", "Eighty six symptomatic BPH patients with International Prostate Symptom Score (IPSS) of more than 13 and prostate volume of more than 30\u2009cm<sup>3</sup> were randomly allocated to receive a two-week course of placebo (control group) or 1\u2009mL of mixed hydro-alcoholic solution of P. alkekengi, E. amoenum and V. odorata extracts (1.5, 1 and 1.5% respectively) (treatment group).", "IPSS score of incomplete urination (42.3\u2009\u00b1\u20092.04%), frequency of urination (20.08\u2009\u00b1\u20091.02%), intermittency (40.78\u2009\u00b1\u20092.16%), urgency (60.91\u2009\u00b1\u20093.14%), weak stream (50.58\u2009\u00b1\u20092.14%), straining (55.67\u2009\u00b1\u20092.53%) and nocturia (40.14\u2009\u00b1\u20091.89%) in treatment group were significantly decreased after treatment compare to placebo receiving group. Furthermore, the prostate volume (16.92\u2009\u00b1\u20090.89%) and extant urine volume (28.12\u2009\u00b1\u20091.36%) also significantly decreased in treatment group compared to control group. No significant side effects or abnormalities in biochemical tests and urinalysis were observed throughout the study.", "Based on results, mentioned mixture is safe and effective in improving life quality of patients suffering from BPH."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "a Nephrology and Urology Research Center , Baghiatallah University of Medical Sciences , Tehran , Iran."}], "LastName": "Beiraghdar", "ForeName": "Fatemeh", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "a Nephrology and Urology Research Center , Baghiatallah University of Medical Sciences , Tehran , Iran."}], "LastName": "Einollahi", "ForeName": "Behzad", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "a Nephrology and Urology Research Center , Baghiatallah University of Medical Sciences , Tehran , Iran."}], "LastName": "Ghadyani", "ForeName": "Alireza", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "a Nephrology and Urology Research Center , Baghiatallah University of Medical Sciences , Tehran , Iran."}], "LastName": "Panahi", "ForeName": "Yunes", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "b Department of Pharmacognosy and Medical Plants Research Center Faculty of Pharmacy , Tehran University of Medical Sciences , Tehran , Iran."}], "LastName": "Hadjiakhoondi", "ForeName": "Abbas", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "b Department of Pharmacognosy and Medical Plants Research Center Faculty of Pharmacy , Tehran University of Medical Sciences , Tehran , Iran."}], "LastName": "Vazirian", "ForeName": "Mahdi", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "c Integrative Oncology Department , Breast Cancer Research Center ACECR , Iran."}], "LastName": "Salarytabar", "ForeName": "Ali", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "d Recombinant Proteins Department , Breast Cancer Research Center ACECR , Tehran , Iran."}], "LastName": "Darvishi", "ForeName": "Behrad", "Initials": "B"}], "PublicationTypeList": ["Journal Article", "Randomized Controlled Trial"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Pharm Biol", "NlmUniqueID": "9812552", "ISSNLinking": "1388-0209"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": [], "DescriptorName": "Double-Blind Method"}, {"QualifierName": ["chemistry"], "DescriptorName": "Echium"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["adverse effects", "isolation & purification", "therapeutic use"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["drug effects", "pathology"], "DescriptorName": "Prostate"}, {"QualifierName": ["diagnosis", "drug therapy", "physiopathology"], "DescriptorName": "Prostatic Hyperplasia"}, {"QualifierName": [], "DescriptorName": "Quality of Life"}, {"QualifierName": ["chemistry"], "DescriptorName": "Solanaceae"}, {"QualifierName": [], "DescriptorName": "Time Factors"}, {"QualifierName": [], "DescriptorName": "Treatment Outcome"}, {"QualifierName": ["drug effects"], "DescriptorName": "Urination"}, {"QualifierName": ["chemistry"], "DescriptorName": "Viola"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Aaron L, Franco OE, Hayward SW.. 2016. Review of prostate anatomy and embryology and the etiology of benign prostatic hyperplasia. Urol Clin N Am. 43:279\u2013288.", "ArticleIdList": ["PMC4968575", "27476121"]}, {"Citation": "Abolhassani M.2004. Antibacterial effect of borage (Echium amoenum) on Staphylococcus aureus. Braz J Infect Dis. 8:382\u2013385.", "ArticleIdList": ["15798815"]}, {"Citation": "Alivizatos G, Skolarikos A.. 2008. Obstructive uropathy and benign prostatic hyperplasia. The aging kidney in health and disease. USA: Springer."}, {"Citation": "Andriole G, Bruchovsky N, Chung LW, Matsumoto AM, Rittmaster R, Roehrborn C, Russell D, Tindall D.. 2004. Dihydrotestosterone and the prostate: the scientific rationale for 5\u03b1-reductase inhibitors in the treatment of benign prostatic hyperplasia. J Urol. 172:1399\u20131403.", "ArticleIdList": ["15371854"]}, {"Citation": "Ballabh B, Chaurasia O, Ahmed Z, Singh SB.. 2008. Traditional medicinal plants of cold desert Ladakh-used against kidney and urinary disorders. J Ethnopharmacol. 118:331\u2013339.", "ArticleIdList": ["18550306"]}, {"Citation": "Berges R, Windeler J, Trampisch H, Senge T. Group \u03b2-SS . 1995. Randomised, placebo-controlled, double-blind clinical trial of \u03b2-sitosterol in patients with benign prostatic hyperplasia. Lancet. 345:1529\u20131532.", "ArticleIdList": ["7540705"]}, {"Citation": "Bostanci Y, Kazzazi A, Momtahen S, Laze J, Djavan B.. 2013. Correlation between benign prostatic hyperplasia and inflammation. Curr Opin Urol. 23:5\u201310.", "ArticleIdList": ["23159991"]}, {"Citation": "Breyer BN, Kenfield SA, Blaschko SD, Erickson BA.. 2014. The association of lower urinary tract symptoms, depression and suicidal ideation: data from the 2005\u20132006 and 2007\u20132008 National Health and Nutrition Examination Survey. J Urol. 191:1333\u20131339.", "ArticleIdList": ["PMC4122308", "24342145"]}, {"Citation": "Bullock TL, Andriole GL. Jr.. 2006. Emerging drug therapies for benign prostatic hyperplasia. Expert Opin Emerg Drugs. 11:111\u2013123.", "ArticleIdList": ["16503830"]}, {"Citation": "Chinese Pharmacopoeia Committee 2005. Pharmacopoeia of the People\u2019s Republic of China. Vol. 1 Beijing, China: Chemical Industry Press; p. 250\u2013251."}, {"Citation": "Chughtai B, Lee R, Te A, Kaplan S.. 2011. Role of inflammation in benign prostatic hyperplasia. Rev Urol. 13:147\u2013150.", "ArticleIdList": ["PMC3221555", "22110398"]}, {"Citation": "Clark RV, Hermann DJ, Cunningham GR, Wilson TH, Morrill BB, Hobbs S.. 2004. Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor. J Clin Endocrinol Metab. 89:2179\u20132184.", "ArticleIdList": ["15126539"]}, {"Citation": "Debruyne FM.2000. Alpha blockers: are all created equal? Urology. 56:20\u201322.", "ArticleIdList": ["11074198"]}, {"Citation": "Drozdova I, Bubenchikov R.. 2005. Composition and antiinflammatory activity of polysaccharide complexes extracted from sweet violet and low mallow. Pharm Chem. 39:197\u2013200."}, {"Citation": "Dweck AC.2006. Isoflavones, phytohormones and phytosterols. J Appl Cosmetol. 24:17."}, {"Citation": "Engel W.1964. Uropsychiatry. J Mich State Med Soc. 63:273.", "ArticleIdList": ["14139585"]}, {"Citation": "Gharib Naseri MK, Mohammadian M, Gharib Naseri Pharm Z.. 2008. Antispasmodic effect of Physalis alkekengi fruit extract. Int J Reprod Biomed. 6:193\u2013198."}, {"Citation": "Gormley GJ, Stoner E, Bruskewitz RC, Imperato-McGinley J, Walsh PC, McConnell JD, Andriole GL, Geller J, Bracken BR, Tenover JS.. 1992. The effect of finasteride in men with benign prostatic hyperplasia. N Engl J Med. 327:1185\u20131191.", "ArticleIdList": ["1383816"]}, {"Citation": "Huri HZ, Xin CH, Sulaiman CZ.. 2014. Drug-related problems in patients with benign prostatic hyperplasia: a cross sectional retrospective study. PLoS One. 9:e86215.", "ArticleIdList": ["PMC3903504", "24475089"]}, {"Citation": "Johnson TV, Abbasi A, Ehrlich SS, Kleris RS, Raison CL, Master VA.. 2011. Nocturia associated with depressive symptoms. Urology. 77:183\u2013186.", "ArticleIdList": ["20599253"]}, {"Citation": "Keehn A, Lowe FC.. 2015. Complementary and alternative medications for benign prostatic hyperplasia. Can J Urol. 22:18\u201323.", "ArticleIdList": ["26497340"]}, {"Citation": "Keehn A, Taylor J, Lowe FC.. 2016. Phytotherapy for benign prostatic hyperplasia. Curr Urol Rep. 17:1\u20136.", "ArticleIdList": ["27180172"]}, {"Citation": "Kim EH, Larson JA, Andriole GL.. 2016. Management of benign prostatic hyperplasia. Annu Rev Med. 67:137\u2013151.", "ArticleIdList": ["26331999"]}, {"Citation": "Klippel K, Hiltl D, Schipp B.. 1997. A multicentric, placebo-controlled, double-blind clinical trial of beta-sitosterol (phytosterol) for the treatment of benign prostatic hyperplasia. German BPH-Phyto Study group. Br J Urol. 80:427\u2013432.", "ArticleIdList": ["9313662"]}, {"Citation": "Lim T.2014. Viola odorata In: Lim TK, editor. Edible medicinal and non medicinal plants. New York: Springer; p. 795\u2013807."}, {"Citation": "MacDonald R, Tacklind JW, Rutks I, Wilt TJ.. 2012. Serenoa repens monotherapy for benign prostatic hyperplasia (BPH): an updated Cochrane systematic review. BJU Int. 109:1756\u20131761.", "ArticleIdList": ["PMC3513282", "22551330"]}, {"Citation": "Miller J, Tarter T.. 2009. Combination therapy with dutasteride and tamsulosin for the treatment of symptomatic enlarged prostate. Clin Interv Aging. 4:251\u2013258.", "ArticleIdList": ["PMC2697590", "19554096"]}, {"Citation": "Mittal S.2013. Thin layer chromatography and high pressure liquid chromatography profiling of plant extracts of Viola odorata L. Int J Pharma Bio Sci. 4:B542\u2013B549."}, {"Citation": "Molinuevo B, Batista\u2010Miranda JE.. 2012. Under the tip of the iceberg: psychological factors in incontinence. Neurourol Urodyn. 31:669\u2013671.", "ArticleIdList": ["22473905"]}, {"Citation": "Narayan P, Tunuguntla HSGR.. 2005. Long-term efficacy and safety of tamsulosin for benign prostatic hyperplasia. Rev Urol. 7:S42.", "ArticleIdList": ["PMC1477608", "16986054"]}, {"Citation": "Naser S, Jasem E, Maryam SL, Hassan HS.. 2008. Effects of alcoholic extract of Physalis alkekengi on the reproductive system, spermatogenesis and sex hormones of adult NMRI mice. Pharmacol Online. 3:110\u2013118."}, {"Citation": "Nicholson TM, Ricke WA.. 2011. Androgens and estrogens in benign prostatic hyperplasia: past, present and future. Differentiation. 82:184\u2013199.", "ArticleIdList": ["PMC3179830", "21620560"]}, {"Citation": "Nickel JC.2008. Inflammation and benign prostatic hyperplasia. Urol Clin N Am. 35:109\u2013115.", "ArticleIdList": ["PMC2198849", "18061029"]}, {"Citation": "Qiu L, Zhao F, Liu H, Chen L, Jiang Z, Liu H, Wang N, Yao X, Qiu F.. 2008. Two new megastigmane glycosides, physanosides A and B, from Physalis alkekengi L. var. franchetii, and their effect on NO release in macrophages. Chem Biodiver. 5:758\u2013763.", "ArticleIdList": ["18493962"]}, {"Citation": "Sayyah M, Boostani H, Pakseresht S, Malaieri A.. 2009. Efficacy of aqueous extract of Echium amoenum in treatment of obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 33:1513\u20131516.", "ArticleIdList": ["19737592"]}, {"Citation": "Sayyah M, Sayyah M, Kamalinejad M.. 2006. A preliminary randomized double blind clinical trial on the efficacy of aqueous extract of Echium amoenum in the treatment of mild to moderate major depression. Prog Neuropsychopharmacol Biol Psychiatry. 30:166\u2013169.", "ArticleIdList": ["16309809"]}, {"Citation": "Schalken JA.2015. Inflammation in the pathophysiology of benign prostatic hypertrophy. Eur Urol Suppl. 14:e1455\u2013e1458."}, {"Citation": "Shafaghi B, Naderi N, Tahmasb L, Kamalinejad M.. 2010. Anxiolytic effect of Echium amoenum L. in mice. Iran J Pharm Res. 37\u201341.", "ArticleIdList": ["0"]}, {"Citation": "Shrivastava A, Gupta VB.. 2012. Various treatment options for benign prostatic hyperplasia: a current update. J Midlife Health. 3:10.", "ArticleIdList": ["PMC3425142", "22923974"]}, {"Citation": "Tarter T, Vaughan J.. 2006. Inhibitors of 5alpha-reductase in the treatment of benign prostatic hyperplasia. Curr Pharm Des. 12:775\u2013783.", "ArticleIdList": ["16515494"]}, {"Citation": "Tewari AK, Whelan P, Graham JD.. 2013. Prostate cancer: diagnosis and clinical management. New York: John Wiley & Sons."}, {"Citation": "Untergasser G, Madersbacher S, Berger P.. 2005. Benign prostatic hyperplasia: age-related tissue-remodeling. Exp Gerontol. 40:121\u2013128.", "ArticleIdList": ["15763388"]}, {"Citation": "Vishal A, Parveen K, Pooja S, Kannappan N, Kumar S.. 2009. Diuretic, laxative and toxicity studies of Viola odorata aerial parts. Pharmacol Online. 1:739\u2013748."}, {"Citation": "Wong SY, Woo J, Leung JC, Leung PC.. 2010. Depressive symptoms and lifestyle factors as risk factors of lower urinary tract symptoms in Southern Chinese men: a prospective study. Aging Male. 13:113\u2013119.", "ArticleIdList": ["20429720"]}, {"Citation": "Zegarra L, Vaisberg A, Loza C, Aguirre RL, Campos M, Fernandez I, Talla O, Villegas L.. 2007. Double-blind randomized placebo-controlled study of Bixa orellana in patients with lower urinary tract symptoms associated to benign prostatic hyperplasia. Int Braz J Urol. 33:493\u2013501.", "ArticleIdList": ["17767753"]}]}], "History": [{"Year": "2017", "Month": "5", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "5", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "1", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "5", "Day": "23"}], "PublicationStatus": "ppublish", "ArticleIdList": ["28532232", "PMC6130621", "10.1080/13880209.2017.1328445"]}}]}